|
ZANTAC
|
6505-01-371-7070
|
Ranitidine In Sodium Chloride In |
Glaxo Wellcome Inc
|
|
Quote
|
|
ZANTAC INJECTION PREMIXED
|
6505-01-371-7070
|
Ranitidine In Sodium Chloride In |
Glaxo Wellcome Inc
|
|
Quote
|
|
6505NCM116383
|
6505-01-371-7070
|
Ranitidine In Sodium Chloride In |
Defense Medical Standardization
|
|
Quote
|
|
23781
|
6505-01-371-7070
|
Ranitidine In Sodium Chloride In |
Defense Logistics Agency
|
|
Quote
|
|
NDC00173-0441-00
|
6505-01-371-7070
|
Ranitidine In Sodium Chloride In |
Glaxo Wellcome Inc
|
|
Quote
|
|
2VX
|
6505-01-371-7791
|
Concentrat Hemodialysis Solution |
Bicarbolyte Corp
|
|
Quote
|
|
55A-2VX
|
6505-01-371-7791
|
Concentrat Hemodialysis Solution |
Bicarbolyte Corp
|
|
Quote
|
|
DIANEAL
|
6505-01-371-7792
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corporation
|
|
Quote
|
|
DIANEAL PD-2
|
6505-01-371-7792
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corporation
|
|
Quote
|
|
5B5169
|
6505-01-371-7792
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corporation
|
|
Quote
|
|
NDC00258-3583-10
|
6505-01-371-7815
|
Theophylline Extended-release Ta |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
NDC10356-0090-10
|
6505-01-371-7832
|
Ointment Base |
Beiersdorf Inc
|
|
Quote
|
|
3823
|
6505-01-371-7832
|
Ointment Base |
Beiersdorf Inc
|
|
Quote
|
|
PAXIL
|
6505-01-371-8320
|
Paroxetine Hydrochloride Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
321213
|
6505-01-371-8320
|
Paroxetine Hydrochloride Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3212-13
|
6505-01-371-8320
|
Paroxetine Hydrochloride Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC51079-0774-20
|
6505-01-371-8321
|
Paroxetine Hydrochloride Tablets |
Mylan Institutional Inc.
|
|
Quote
|
|
PAXIL
|
6505-01-371-8322
|
Paroxetine Hydrochloride Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
321120
|
6505-01-371-8322
|
Paroxetine Hydrochloride Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3211-20
|
6505-01-371-8322
|
Paroxetine Hydrochloride Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
PAXIL
|
6505-01-371-8323
|
Paroxetine Hydrochloride Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
321113
|
6505-01-371-8323
|
Paroxetine Hydrochloride Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
NDC00029-3211-13
|
6505-01-371-8323
|
Paroxetine Hydrochloride Tablets |
Glaxosmithkline Holdings Americas
|
|
Quote
|
|
00054309036
|
6505-01-371-8384
|
Butorphanol Tartrate Nasal Solut |
Roxane Laboratories, Inc.
|
|
Quote
|
|
NDC00054-3090-36
|
6505-01-371-8384
|
Butorphanol Tartrate Nasal Solut |
Roxane Laboratories, Inc.
|
|
Quote
|
|
00378963943
|
6505-01-371-8384
|
Butorphanol Tartrate Nasal Solut |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00378-9639-43
|
6505-01-371-8384
|
Butorphanol Tartrate Nasal Solut |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00087-5650-41
|
6505-01-371-8384
|
Butorphanol Tartrate Nasal Solut |
Bristol-myers Squibb Pharmaceutical
|
|
Quote
|
|
NDC10135-0203-13
|
6505-01-371-9633
|
Usp Simethicone Tablets |
Marlex Pharmaceutical
|
|
Quote
|
|
SURVANTA
|
6505-01-372-0173
|
Beractant Intratracheal Suspensi |
Abbott Laboratories Inc
|
|
Quote
|
|
F93A339
|
6505-01-372-0173
|
Beractant Intratracheal Suspensi |
Air Force Medical Logistics Office
|
|
Quote
|
|
NDC00074-1040-08
|
6505-01-372-0173
|
Beractant Intratracheal Suspensi |
Abbott Laboratories Inc
|
|
Quote
|
|
NDC00074-1040-08
|
6505-01-372-0173
|
Beractant Intratracheal Suspensi |
Ross Laboratories, Inc.
|
|
Quote
|
|
SURVANTA
|
6505-01-372-0173
|
Beractant Intratracheal Suspensi |
Ross Laboratories, Inc.
|
|
Quote
|
|
GORMEL
|
6505-01-372-1291
|
Urea Cream |
Dercher Enterprises Inc
|
|
Quote
|
|
GORMEL CREAM
|
6505-01-372-1291
|
Urea Cream |
Dercher Enterprises Inc
|
|
Quote
|
|
3001-02
|
6505-01-372-1291
|
Urea Cream |
Dercher Enterprises Inc
|
|
Quote
|
|
NDC10481-3001-02
|
6505-01-372-1291
|
Urea Cream |
Dercher Enterprises Inc
|
|
Quote
|
|
2B0163Q
|
6505-01-372-3422
|
Usp Dextrose Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0023-03
|
6505-01-372-3422
|
Usp Dextrose Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
7930-03
|
6505-01-372-3422
|
Usp Dextrose Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00409-7930-03
|
6505-01-372-3422
|
Usp Dextrose Injection |
Hospira, Inc.
|
|
Quote
|
|
L5201
|
6505-01-372-3422
|
Usp Dextrose Injection |
B Braun Medical Inc
|
|
Quote
|
|
2B1073Q
|
6505-01-372-3423
|
Dextrose And Sodium Chloride Inj |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0085-03
|
6505-01-372-3423
|
Dextrose And Sodium Chloride Inj |
Baxter Healthcare Corp
|
|
Quote
|
|
7926-03
|
6505-01-372-3423
|
Dextrose And Sodium Chloride Inj |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-7926-03
|
6505-01-372-3423
|
Dextrose And Sodium Chloride Inj |
Abbott Laboratories Inc.
|
|
Quote
|
|
L6121
|
6505-01-372-3423
|
Dextrose And Sodium Chloride Inj |
B Braun Medical Inc
|
|
Quote
|
|
NDC00074-7983-03
|
6505-01-372-3425
|
Usp Sodium Chloride Injection |
Hospira, Inc.
|
|
Quote
|
|
A93A038
|
6505-01-372-3426
|
Octreotide Acetate Injection |
Department of the Army
|
|
Quote
|
|
SANDOSTATIN
|
6505-01-372-3426
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00078-0184-25
|
6505-01-372-3426
|
Octreotide Acetate Injection |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00686-0805-25
|
6505-01-372-4318
|
Usp Atropine Sulfate Injection |
Raway Pharmacal Inc
|
|
Quote
|
|
012111-004
|
6505-01-372-4319
|
Concentrat Hemodialysis Solution |
Cobe Laboratories Inc
|
|
Quote
|
|
012-111-02
|
6505-01-372-4319
|
Concentrat Hemodialysis Solution |
Cobe Laboratories Inc
|
|
Quote
|
|
NDC00338-0111-03
|
6505-01-372-4484
|
Dextrose In Ringer's Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
2B2063Q
|
6505-01-372-4484
|
Dextrose In Ringer's Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
7933-03
|
6505-01-372-4484
|
Dextrose In Ringer's Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-7933-03
|
6505-01-372-4484
|
Dextrose In Ringer's Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00409-7941-03
|
6505-01-372-4485
|
Dextrose And Sodium Chloride Inj |
Hospira, Inc.
|
|
Quote
|
|
07924-03
|
6505-01-372-4486
|
Dextrose And Sodium Chloride Inj |
Hospira, Inc.
|
|
Quote
|
|
NDC00409-7924-03
|
6505-01-372-4486
|
Dextrose And Sodium Chloride Inj |
Hospira, Inc.
|
|
Quote
|
|
2B1093Q
|
6505-01-372-4486
|
Dextrose And Sodium Chloride Inj |
Baxter Healthcare Corporation
|
|
Quote
|
|
NDC00338-0077-03
|
6505-01-372-4486
|
Dextrose And Sodium Chloride Inj |
Baxter Healthcare Corporation
|
|
Quote
|
|
ANA-GUARD
|
6505-01-372-4487
|
Usp Epinephrine Injection |
Miles Inc
|
|
Quote
|
|
F92L461
|
6505-01-372-4487
|
Usp Epinephrine Injection |
Air Force Medical Logistics Office
|
|
Quote
|
|
6815ZA
|
6505-01-372-4487
|
Usp Epinephrine Injection |
Miles Inc
|
|
Quote
|
|
ANA-GUARD
|
6505-01-372-4487
|
Usp Epinephrine Injection |
Idis
|
|
Quote
|
|
2B2303Q
|
6505-01-372-4488
|
Usp Ringer's Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0105-03
|
6505-01-372-4488
|
Usp Ringer's Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
7982-24
|
6505-01-372-4488
|
Usp Ringer's Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-7982-24
|
6505-01-372-4488
|
Usp Ringer's Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00409-1483-03
|
6505-01-372-4489
|
Nitroglycerin In Dextrose Inject |
Hospira, Inc.
|
|
Quote
|
